Liberum Biotech-preview

Liberumbio

Liberum Biotech

Private

San Francisco, CaliforniaHealthcare & Life Scienceshttps://liberumbio.com/

Last Round

Seed

Jul 24, 2023

Total Funding Raised

$2.05M

Momentum Score

25 /100

Company Overview

Liberum Biotech is a biotechnology company that provides a cell-free protein synthesis platform to accelerate protein and antibody discovery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Infrastructure

Keywords

cell-free protein synthesisprotein synthesis serviceCFPSprotein prototypingprotein engineeringprotein printingbio-foundryenzyme discoveryantibody discoverylab-in-the-loopsequence-to-function dataAI protein designbiotech equipmentbenchtop protein synthesiscell-free expressionnanobody expression

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Liberum Biotech Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Liberum Biotech Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Seed	Jul 24, 2023
Accelerator	Jun 11, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Alexander Klenov

Chief Technology Officer And Co-Founder

Founding Team

Liberum Biotech Investors

Notable investors and investment history

Investor	Rounds
TechU Ventures	Seed
Creative Destruction Lab	Accelerator
Velocity	Accelerator
IndieBio	Accelerator
Savantus Ventures	Seed
SOSV	Accelerator, Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 1, 2026
Monthly visitors increased 207% MoM to 3.9K.
May 4, 2025
Monthly visitors grew 121% MoM, reaching 1.7K.

View all signals

Liberum Biotech Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Liberum Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Liberum Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California

Employee Range7

Year Founded2019

Last FundingJul 24, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.